{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T11:01:18Z","timestamp":1777978878426,"version":"3.51.4"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation program","award":["667787 (UM Cure)"],"award-info":[{"award-number":["667787 (UM Cure)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-90122-z","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:19:51Z","timestamp":1741576791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of diagnostic and prognostic genetic alterations in uveal melanoma using RNA sequencing"],"prefix":"10.1038","volume":"15","author":[{"given":"Rogier J.","family":"Nell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieke","family":"Versluis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davy","family":"Cats","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailiang","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M.","family":"Verdijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilma G. M.","family":"Kroes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregorius P. M.","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine J.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter A.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"90122_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager, M. J. et al. Uveal melanoma. Nat. Rev. Dis. Prim. 6, 24. https:\/\/doi.org\/10.1038\/s41572-020-0158-0 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"90122_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","volume":"3","author":"SJ Furney","year":"2013","unstructured":"Furney, S. J. et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov. 3, 1122\u20131129. https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0330 (2013).","journal-title":"Cancer Discov."},{"key":"90122_CR3","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.ajhg.2016.09.008","volume":"99","author":"B Royer-Bertrand","year":"2016","unstructured":"Royer-Bertrand, B. et al. Comprehensive genetic landscape of uveal melanoma by whole-genome sequencing. Am. J. Hum. Genet. 99, 1190\u20131198. https:\/\/doi.org\/10.1016\/j.ajhg.2016.09.008 (2016).","journal-title":"Am. J. Hum. Genet."},{"key":"90122_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature07586","volume":"457","author":"CD Van Raamsdonk","year":"2009","unstructured":"Van Raamsdonk, C. D. et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature 457, 599\u2013602. https:\/\/doi.org\/10.1038\/nature07586 (2009).","journal-title":"Nature"},{"key":"90122_CR5","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","volume":"363","author":"CD Van Raamsdonk","year":"2010","unstructured":"Van Raamsdonk, C. D. et al. Mutations in GNA11 in uveal melanoma. N. Engl. J. Med. 363, 2191\u20132199. https:\/\/doi.org\/10.1056\/NEJMoa1000584 (2010).","journal-title":"N. Engl. J. Med."},{"key":"90122_CR6","doi-asserted-by":"publisher","first-page":"4624","DOI":"10.18632\/oncotarget.6614","volume":"7","author":"P Johansson","year":"2016","unstructured":"Johansson, P. et al. Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4. Oncotarget 7, 4624\u20134631. https:\/\/doi.org\/10.18632\/oncotarget.6614 (2016).","journal-title":"Oncotarget"},{"key":"90122_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/ng.3549","volume":"48","author":"AR Moore","year":"2016","unstructured":"Moore, A. R. et al. Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nat. Genet. 48, 675\u2013680. https:\/\/doi.org\/10.1038\/ng.3549 (2016).","journal-title":"Nat. Genet."},{"key":"90122_CR8","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1126\/science.1194472","volume":"330","author":"JW Harbour","year":"2010","unstructured":"Harbour, J. W. et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410\u20131413. https:\/\/doi.org\/10.1126\/science.1194472 (2010).","journal-title":"Science"},{"key":"90122_CR9","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/ng.2523","volume":"45","author":"JW Harbour","year":"2013","unstructured":"Harbour, J. W. et al. Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma. Nat. Genet. 45, 133\u2013135. https:\/\/doi.org\/10.1038\/ng.2523 (2013).","journal-title":"Nat. Genet."},{"key":"90122_CR10","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/ng.2674","volume":"45","author":"M Martin","year":"2013","unstructured":"Martin, M. et al. Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat. Genet. 45, 933\u2013936. https:\/\/doi.org\/10.1038\/ng.2674 (2013).","journal-title":"Nat. Genet."},{"key":"90122_CR11","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/0140-6736(92)90861-V","volume":"339","author":"G Prescher","year":"1992","unstructured":"Prescher, G., Bornfeld, N., Horsthemke, B. & Becher, R. Chromosomal aberrations defining uveal melanoma of poor prognosis. Lancet 339, 691\u2013692 (1992).","journal-title":"Lancet"},{"key":"90122_CR12","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/1097-0142(19930201)71:3<811::AID-CNCR2820710325>3.0.CO;2-F","volume":"71","author":"DE Horsman","year":"1993","unstructured":"Horsman, D. E. & White, V. A. Cytogenetic analysis of uveal melanoma. Consistent occurrence of monosomy 3 and trisomy 8q. Cancer 71, 811\u2013819 (1993).","journal-title":"Cancer"},{"key":"90122_CR13","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/(sici)1098-2264(199705)19:1<22::aid-gcc4>3.0.co;2-2","volume":"19","author":"K Sisley","year":"1997","unstructured":"Sisley, K. et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 19, 22\u201328. https:\/\/doi.org\/10.1002\/(sici)1098-2264(199705)19:1%3c22::aid-gcc4%3e3.0.co;2-2 (1997).","journal-title":"Genes Chromosomes Cancer"},{"key":"90122_CR14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.0.CO;2-R","volume":"83","author":"VA White","year":"1998","unstructured":"White, V. A., Chambers, J. D., Courtright, P. D., Chang, W. Y. & Horsman, D. E. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 83, 354\u2013359 (1998).","journal-title":"Cancer"},{"key":"90122_CR15","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1167\/iovs.08-3165","volume":"50","author":"B Damato","year":"2009","unstructured":"Damato, B. et al. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest. Ophthalmol. Vis. Sci. 50, 3048\u20133055. https:\/\/doi.org\/10.1167\/iovs.08-3165 (2009).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"90122_CR16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/modpathol.2017.187","volume":"31","author":"KN Smit","year":"2018","unstructured":"Smit, K. N. et al. Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma. Mod. Pathol. 31, 763\u2013771. https:\/\/doi.org\/10.1038\/modpathol.2017.187 (2018).","journal-title":"Mod. Pathol."},{"key":"90122_CR17","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3390\/cancers12041039","volume":"12","author":"S Thornton","year":"2020","unstructured":"Thornton, S. et al. targeted next-generation sequencing of 117 routine clinical samples provides further insights into the molecular landscape of uveal melanoma. Cancers (Basel) 12, 1039. https:\/\/doi.org\/10.3390\/cancers12041039 (2020).","journal-title":"Cancers (Basel)"},{"key":"90122_CR18","first-page":"2578","volume":"63","author":"F Tschentscher","year":"2003","unstructured":"Tschentscher, F. et al. Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. Cancer Res. 63, 2578\u20132584 (2003).","journal-title":"Cancer Res."},{"key":"90122_CR19","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1038\/sj.bjc.6601374","volume":"89","author":"W Zuidervaart","year":"2003","unstructured":"Zuidervaart, W. et al. Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development. Br. J. Cancer 89, 1914\u20131919. https:\/\/doi.org\/10.1038\/sj.bjc.6601374 (2003).","journal-title":"Br. J. Cancer"},{"key":"90122_CR20","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1158\/0008-5472.CAN-04-1750","volume":"64","author":"MD Onken","year":"2004","unstructured":"Onken, M. D., Worley, L. A., Ehlers, J. P. & Harbour, J. W. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 64, 7205\u20137209. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-1750 (2004).","journal-title":"Cancer Res."},{"key":"90122_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ccell.2017.07.003","volume":"32","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Integrative analysis identifies four molecular and clinical subsets in uveal melanoma. Cancer Cell 32, 204\u2013220. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.003 (2017).","journal-title":"Cancer Cell"},{"key":"90122_CR22","doi-asserted-by":"publisher","first-page":"37824","DOI":"10.18632\/oncotarget.5637","volume":"6","author":"MJ de Lange","year":"2015","unstructured":"de Lange, M. J. et al. Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma. Oncotarget 6, 37824\u201337835. https:\/\/doi.org\/10.18632\/oncotarget.5637 (2015).","journal-title":"Oncotarget"},{"key":"90122_CR23","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1158\/1541-7786.MCR-18-0114","volume":"16","author":"MJ de Lange","year":"2018","unstructured":"de Lange, M. J. et al. Digital PCR-based T-cell quantification-assisted deconvolution of the microenvironment reveals that activated macrophages drive tumor inflammation in uveal melanoma. Mol. Cancer Res 16, 1902\u20131911. https:\/\/doi.org\/10.1158\/1541-7786.MCR-18-0114 (2018).","journal-title":"Mol. Cancer Res"},{"key":"90122_CR24","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1038\/ncomms10615","volume":"7","author":"S Alsafadi","year":"2016","unstructured":"Alsafadi, S. et al. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Nat. Commun. 7, 10615. https:\/\/doi.org\/10.1038\/ncomms10615 (2016).","journal-title":"Nat. Commun."},{"key":"90122_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41467-017-02428-w","volume":"9","author":"MG Field","year":"2018","unstructured":"Field, M. G. et al. Punctuated evolution of canonical genomic aberrations in uveal melanoma. Nat. Commun. 9, 116. https:\/\/doi.org\/10.1038\/s41467-017-02428-w (2018).","journal-title":"Nat. Commun."},{"key":"90122_CR26","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/s41467-020-15606-0","volume":"11","author":"J Karlsson","year":"2020","unstructured":"Karlsson, J. et al. Molecular profiling of driver events in metastatic uveal melanoma. Nat. Commun. 11, 1894. https:\/\/doi.org\/10.1038\/s41467-020-15606-0 (2020).","journal-title":"Nat. Commun."},{"key":"90122_CR27","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12885-021-07865-x","volume":"21","author":"RJ Nell","year":"2021","unstructured":"Nell, R. J. et al. Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma. BMC Cancer 21, 164. https:\/\/doi.org\/10.1186\/s12885-021-07865-x (2021).","journal-title":"BMC Cancer"},{"key":"90122_CR28","doi-asserted-by":"publisher","unstructured":"Nell, R. J. et al. Allele-specific digital PCR enhances precision and sensitivity in the detection and quantification of copy number alterations in heterogeneous DNA samples: an in silico and in vitro validation study. medRxiv, https:\/\/doi.org\/10.1101\/2023.10.31.23297362 (2023).","DOI":"10.1101\/2023.10.31.23297362"},{"key":"90122_CR29","doi-asserted-by":"publisher","unstructured":"Nell, R. J. et al. Digital PCR-based deep quantitative profiling delineates heterogeneity and evolution of uveal melanoma. medRxiv. https:\/\/doi.org\/10.1101\/2024.01.30.24301871 (2024).","DOI":"10.1101\/2024.01.30.24301871"},{"key":"90122_CR30","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/nrg775","volume":"3","author":"L Cartegni","year":"2002","unstructured":"Cartegni, L., Chew, S. L. & Krainer, A. R. Listening to silence and understanding nonsense: Exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285\u2013298. https:\/\/doi.org\/10.1038\/nrg775 (2002).","journal-title":"Nat. Rev. Genet."},{"key":"90122_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1261\/rna.7182905","volume":"11","author":"F Mohn","year":"2005","unstructured":"Mohn, F., Buhler, M. & Muhlemann, O. Nonsense-associated alternative splicing of T-cell receptor beta genes: No evidence for frame dependence. RNA 11, 147\u2013156. https:\/\/doi.org\/10.1261\/rna.7182905 (2005).","journal-title":"RNA"},{"key":"90122_CR32","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1093\/hmg\/ddz076","volume":"28","author":"P Repo","year":"2019","unstructured":"Repo, P. et al. Population-based analysis of BAP1 germline variations in patients with uveal melanoma. Hum. Mol. Genet. 28, 2415\u20132426. https:\/\/doi.org\/10.1093\/hmg\/ddz076 (2019).","journal-title":"Hum. Mol. Genet."},{"key":"90122_CR33","doi-asserted-by":"publisher","first-page":"102173","DOI":"10.1016\/j.isci.2021.102173","volume":"24","author":"J Niersch","year":"2021","unstructured":"Niersch, J. et al. A BAP1 synonymous mutation results in exon skipping, loss of function and worse patient prognosis. iScience 24, 102173. https:\/\/doi.org\/10.1016\/j.isci.2021.102173 (2021).","journal-title":"iScience"},{"key":"90122_CR34","doi-asserted-by":"publisher","first-page":"4105","DOI":"10.3390\/cancers14174105","volume":"14","author":"YC Cole","year":"2022","unstructured":"Cole, Y. C. et al. Correlation between BAP1 localization, driver mutations, and patient survival in uveal melanoma. Cancers (Basel) 14, 4105. https:\/\/doi.org\/10.3390\/cancers14174105 (2022).","journal-title":"Cancers (Basel)"},{"key":"90122_CR35","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/annonc\/mdx765","volume":"29","author":"AK Krug","year":"2018","unstructured":"Krug, A. K. et al. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Ann. Oncol. 29, 700\u2013706. https:\/\/doi.org\/10.1093\/annonc\/mdx765 (2018).","journal-title":"Ann. Oncol."},{"key":"90122_CR36","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41597-022-01176-x","volume":"9","author":"K Schoofs","year":"2022","unstructured":"Schoofs, K. et al. Comprehensive RNA dataset of tissue and plasma from patients with esophageal cancer or precursor lesions. Sci. Data 9, 86. https:\/\/doi.org\/10.1038\/s41597-022-01176-x (2022).","journal-title":"Sci. Data"},{"key":"90122_CR37","doi-asserted-by":"publisher","first-page":"e1090","DOI":"10.1002\/ctm2.1090","volume":"12","author":"LJ Albrecht","year":"2022","unstructured":"Albrecht, L. J. et al. Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype. Clin. Transl. Med. 12, e1090. https:\/\/doi.org\/10.1002\/ctm2.1090 (2022).","journal-title":"Clin. Transl. Med."},{"key":"90122_CR38","doi-asserted-by":"publisher","first-page":"e16261","DOI":"10.1016\/j.heliyon.2023.e16261","volume":"9","author":"M Albitar","year":"2023","unstructured":"Albitar, M. et al. Combining cell-free RNA with cell-free DNA in liquid biopsy for hematologic and solid tumors. Heliyon 9, e16261. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16261 (2023).","journal-title":"Heliyon"},{"key":"90122_CR39","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3390\/cancers11081200","volume":"11","author":"NM van Poppelen","year":"2019","unstructured":"van Poppelen, N. M. et al. SRSF2 mutations in uveal melanoma: a preference for in-frame deletions. Cancers (Basel) 11, 1200. https:\/\/doi.org\/10.3390\/cancers11081200 (2019).","journal-title":"Cancers (Basel)"},{"key":"90122_CR40","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/s41467-018-04322-5","volume":"9","author":"M Rodrigues","year":"2018","unstructured":"Rodrigues, M. et al. Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors. Nat. Commun. 9, 1866. https:\/\/doi.org\/10.1038\/s41467-018-04322-5 (2018).","journal-title":"Nat. Commun."},{"key":"90122_CR41","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00251-019-01108-x","volume":"71","author":"PA Johansson","year":"2019","unstructured":"Johansson, P. A. et al. Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab. Immunogenetics 71, 433\u2013436. https:\/\/doi.org\/10.1007\/s00251-019-01108-x (2019).","journal-title":"Immunogenetics"},{"key":"90122_CR42","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1038\/s41467-022-30753-2","volume":"13","author":"R Katzir","year":"2022","unstructured":"Katzir, R., Rudberg, N. & Yizhak, K. Estimating tumor mutational burden from RNA-sequencing without a matched-normal sample. Nat. Commun. 13, 3092. https:\/\/doi.org\/10.1038\/s41467-022-30753-2 (2022).","journal-title":"Nat. Commun."},{"key":"90122_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676\u2013689. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.007 (2018).","journal-title":"Cancer Cell"},{"key":"90122_CR44","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/978-1-4939-8885-3_1","volume":"1\u201314","author":"WH Zoutman","year":"1884","unstructured":"Zoutman, W. H., Nell, R. J. & van der Velden, P. A. Usage of droplet digital PCR (ddPCR) assays for T cell quantification in cancer. Methods Mol. Biol. 1\u201314, 2019. https:\/\/doi.org\/10.1007\/978-1-4939-8885-3_1 (1884).","journal-title":"Methods Mol. Biol."},{"key":"90122_CR45","doi-asserted-by":"publisher","first-page":"e0116371","DOI":"10.1371\/journal.pone.0116371","volume":"10","author":"M Versluis","year":"2015","unstructured":"Versluis, M. et al. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma. PLoS One 10, e0116371. https:\/\/doi.org\/10.1371\/journal.pone.0116371 (2015).","journal-title":"PLoS One"},{"key":"90122_CR46","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/bjophthalmol-2014-305047","volume":"98","author":"TH van Essen","year":"2014","unstructured":"van Essen, T. H. et al. Prognostic parameters in uveal melanoma and their association with BAP1 expression. Br. J. Ophthalmol. 98, 1738\u20131743. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305047 (2014).","journal-title":"Br. J. Ophthalmol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90122-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90122-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90122-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T15:07:08Z","timestamp":1741619228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-90122-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["90122"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-90122-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"23 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8167"}}